FNBT
BIIB icon

FineMark National Bank & Trust’s Biogen BIIB Stock Holding History

FineMark National Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$257K Buy
+1,463
New +$239K 0.01% 398
2025
Q2 		– Sell
-1,486
Closed -$203K – 457
2025
Q1 		$203K Hold
1,486
– – 0.01% 422
2024
Q4 		$227K Sell
1,486
-121
-8% -$20.4K 0.01% 389
2024
Q3 		$312K Buy
1,607
+72
+5% +$15.1K 0.01% 345
2024
Q2 		$356K Sell
1,535
-117
-7% -$25.4K 0.01% 324
2024
Q1 		$356K Buy
1,652
+540
+49% +$126K 0.01% 328
2023
Q4 		$288K Sell
1,112
-136
-11% -$33.4K 0.01% 338
2023
Q3 		$321K Buy
1,248
+25
+2% +$6.69K 0.01% 320
2023
Q2 		$348K Buy
1,223
+28
+2% +$8.34K 0.01% 323
2023
Q1 		$332K Sell
1,195
-986
-45% -$273K 0.01% 321
2022
Q4 		$604K Sell
2,181
-47
-2% -$13.3K 0.03% 240
2022
Q3 		$595K Buy
2,228
+8
+0.4% +$1.7K 0.03% 236
2022
Q2 		$453K Buy
2,220
+32
+1% +$6.54K 0.02% 283
2022
Q1 		$461K Sell
2,188
-457
-17% -$99.4K 0.02% 302
2021
Q4 		$635K Sell
2,645
-57
-2% -$14.7K 0.02% 271
2021
Q3 		$765K Sell
2,702
-41
-1% -$13.4K 0.03% 234
2021
Q2 		$950K Sell
2,743
-159
-5% -$48.2K 0.04% 223
2021
Q1 		$812K Sell
2,902
-30
-1% -$8.09K 0.03% 229
2020
Q4 		$718K Buy
2,932
+32
+1% +$8.26K 0.03% 231
2020
Q3 		$823K Sell
2,900
-94
-3% -$26.2K 0.04% 203
2020
Q2 		$801K Buy
2,994
+39
+1% +$11.7K 0.04% 188
2020
Q1 		$935K Buy
2,955
+110
+4% +$33.4K 0.06% 165
2019
Q4 		$844K Buy
2,845
+49
+2% +$13.6K 0.04% 195
2019
Q3 		$651K Sell
2,796
-11
-0.4% -$2.56K 0.03% 218
2019
Q2 		$656K Buy
2,807
+692
+33% +$160K 0.04% 216
2019
Q1 		$500K Sell
2,115
-307
-13% -$96.7K 0.03% 227
2018
Q4 		$729K Buy
2,422
+898
+59% +$287K 0.05% 195
2018
Q3 		$538K Sell
1,524
-6,880
-82% -$2.37M 0.03% 214
2018
Q2 		$2.44M Buy
8,404
+672
+9% +$189K 0.15% 112
2018
Q1 		$2.12M Buy
7,732
+2,563
+50% +$796K 0.13% 117
2017
Q4 		$1.65M Buy
5,169
+1,245
+32% +$399K 0.1% 129
2017
Q3 		$1.23M Buy
3,924
+830
+27% +$246K 0.08% 145
2017
Q2 		$840K Buy
3,094
+2,112
+215% +$558K 0.06% 165
2017
Q1 		$268K Buy
982
+212
+28% +$59.9K 0.02% 305
2016
Q4 		$218K Sell
770
-142
-16% -$42.1K 0.02% 320
2016
Q3 		$285K Sell
912
-28
-3% -$8.29K 0.03% 279
2016
Q2 		$228K Sell
940
-57
-6% -$15K 0.03% 293
2016
Q1 		$259K Sell
997
-1,068
-52% -$282K 0.03% 276
2015
Q4 		$632K Buy
2,065
+28
+1% +$8.05K 0.08% 178
2015
Q3 		$595K Sell
2,037
-111
-5% -$36.7K 0.08% 184
2015
Q2 		$867K Sell
2,148
-72
-3% -$28.9K 0.11% 160
2015
Q1 		$937K Buy
2,220
+4
+0.2% +$1.58K 0.13% 152
2014
Q4 		$753K Buy
2,216
+47
+2% +$15.2K 0.11% 165
2014
Q3 		$717K Sell
2,169
-81
-4% -$26.7K 0.11% 162
2014
Q2 		$710K Sell
2,250
-50
-2% -$15K 0.12% 162
2014
Q1 		$703K Buy
2,300
+260
+13% +$82.5K 0.13% 156
2013
Q4 		$570K Buy
2,040
+96
+5% +$24.8K 0.12% 170
2013
Q3 		$468K Sell
1,944
-3
-0.2% -$671 0.12% 167
2013
Q2 		$419K Buy
+1,947
New +$416K 0.13% 145

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FineMark National Bank & Trust's BIIB Position: Q4 2025 in Review

FineMark National Bank & Trust opened a new position in Biogen (BIIB) in Q4 2025: 1,463 shares worth $257K. The stake represents 0.01% of the portfolio and ranks #398 among its holdings. This is a return to the name: FineMark National Bank & Trust previously reported a position in BIIB as recently as Q1 2025.

FineMark National Bank & Trust first reported a position in BIIB in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.44M in Q2 2018. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • FineMark National Bank & Trust held 1,463 shares of Biogen worth $257K as of Q4 2025.
  • Biogen was a new FineMark National Bank & Trust position in Q4 2025.
  • Biogen made up 0.01% of FineMark National Bank & Trust's portfolio in Q4 2025, its #398 holding.
  • FineMark National Bank & Trust first reported a position in Biogen in Q2 2013 and has held it in 49 quarters since.
  • FineMark National Bank & Trust's Biogen position peaked at $2.44M in Q2 2018.
  • 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.